MedTech-as-a-Service: Interview with CorVista

The Planetary Health First Mars Next podcast touched down at The MedTech Conference 2024 in Toronto, Canada, which boasted 4,350 attendees and over 550 sessions and speakers. Orthogonal and PHFMN’s podcast series features insights from executives representing 17 groundbreaking companies at the frontlines of #MedTech Innovation.?

Host Michael Mann, MHA and Orthogonal ’s Chief Solutions Officer Randy Horton interviewed Don Crawford , President and CEO of CorVista? Health , who discussed how his company is transforming cardiac testing with its medical-device-as-a-service model:

• CorVista’s point-of-care system measures physiologic signals from a patient’s chest and evaluates them with an Artificial Intelligence/Machine Learning algorithm for coronary artery disease and pulmonary hypertension, all within 15 minutes.
• CorVista sells its detection system, powered by its cloud-based AI/ML algorithm, as a service to physicians and doctor’s offices. With its iPad-sized interface and ease of use, CorVista can extend cardiology services to underserved and rural areas.?
• Under this medical-device-as-a-service model, CorVista’s most critical task has become its ability to securely store patient-protected health information in its cloud databases.

Looking for a MedTech developer who's AI-ready? Orthogonal has operated on the leading edge of medical device software development for over 15 years, helping companies navigate AI-enhanced connected medical devices and Software as a Medical Device (#SaMD) through FDA clearance and onto the market. Schedule your call now: https://orthogonal.io/contact-orthogonal/